Efficacy and safety of visnadine in the treatment of symptoms of sexual dysfunction in heterosexual women: a systematic review of randomized clinical trials.
Brenda Caira-ChuquineyraDaniel Fernandez-GuzmánHumberto Garayar-PecerosVicente A Benites-ZapataFaustino Ramón Pérez-LópezJuan E BlümelEdward Mezones-HolguinPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2024)
RCTs regarding the use of visnadine for the Female SD are scarce and methodologically limited. This preliminary evidence shows visnadine as a potentially effective and safe option to alleviate some of the clinical symptoms of SD in heterosexual women. However, future better-designed randomized studies with larger sample numbers are required.
Keyphrases
- polycystic ovary syndrome
- pregnancy outcomes
- double blind
- open label
- cervical cancer screening
- oxidative stress
- mental health
- breast cancer risk
- sleep quality
- randomized controlled trial
- current status
- placebo controlled
- depressive symptoms
- metabolic syndrome
- skeletal muscle
- pregnant women
- case control
- study protocol